Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies.
Palache
A M
AM
Solvay Pharmaceuticals B.V., Weesp, The Netherlands.
Scheepers
H S
HS
de Regt
V
V
van Ewijk
P
P
Baljet
M
M
Brands
R
R
van Scharrenburg
G J
GJ
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D002460:Cell Line; D002642:Chick Embryo; D003257:Consumer Product Safety; D004285:Dogs; D005260:Female; D006801:Humans; D006967:Hypersensitivity; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology*; D007700:Kinetics; D008297:Male; D014422:Turkeys; D014611:Vaccination; D015164:Vaccines, Inactivated / Q000009:adverse effects / Q000276:immunology; D014776:Virus Cultivation
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated